Research and the COVID-19 pandemic

Guidance on virtual research methods

During the COVID-19 pandemic, the University produced guidance on using virtual data collection methods.

Resources on conducting research during the pandemic

• The Global Health Network: epidemic ethics resources
• Health Research Authority: COVID-19 and research
• Medicines and Healthcare products Regulatory Agency: regulatory flexibilities resulting from COVID-19
• National Institute for Health Research: NIHR's response to COVID-19
• National Centre for the Replacement, Refinement, and Reduction of animals in research: the 3Rs during COVID-19
• National Centre for Research Methods: research ethics in COVID-19
• Nuffield Council on Bioethics: research in global health emergencies
• UK Collaborative on Development Research: safeguarding guidance during COVID-19
• UK Research and Innovation: COVID-19 guidance

For information from funders and regulators regarding the COVID-19 pandemic and its impact on research, please see the Research Support Office COVID-19 webpage.

Questions to consider following the learnings of the COVID-19 pandemic

• Are the government safety regulations relating to COVID-19 abided by in the study design
• Are there protocols in place to monitor and adapt to a change in the public health guidelines
• Is the face to face data collection covered by a health and safety risk assessment
• Are all local organisations involved in the study happy for the research to go ahead
• Do the research data collection activities place unreasonable extra demands on other organisations involved in the study
• Does the consent process take into account the context of the COVID-19 pandemic (risks adequately explained; guidance on accessing health care is offered; no undue inducement etc.)
• Is there an explanation of support relating to mental health issues arising from the pandemic
• Will the management of data be affected by any pandemic related restrictions
• Will participation in the study compromise participant’s healthcare needs during the pandemic
• Will the study impact upon local healthcare facilities and resources
• What measures are in place for participant to report any concerns;What mechanisms are in place to ensure that all research partners and participants are receiving accurate, up-to-date information about COVID-19 relevant to their project and country
• Have we taken into account individuals or groups with particular characteristics who risk being affected disproportionately by any changes made to research during this period
• Is the research project extractive in nature
• Are the risks of transmission minimised or proportionate to the value or benefits of the research to the participants
• Do the benefits of face to face research data collection activities outweigh the risks?

Back to: Research